What's Happening?
Cigna has announced that it will begin covering Cleerly LABS Advanced Plaque Analysis, an AI-based cardiovascular imaging technology, starting October 1, 2025. This decision marks a significant expansion in access to advanced cardiovascular care, as Cigna joins other major insurers like UnitedHealthcare and EviCore in recognizing the clinical and economic value of AI-enabled imaging technology. Cleerly's technology provides enhanced clinical insights, supporting clinicians in making more informed care decisions, and represents a pivotal moment for precision medicine in cardiology.
Why It's Important?
The inclusion of Cleerly's AI-based imaging technology in Cigna's coverage is a significant step forward in the adoption of precision medicine. By providing coverage for this advanced technology, Cigna is helping to improve the quality of cardiovascular care for millions of Americans. This move could lead to better patient outcomes by enabling more accurate diagnosis and treatment planning. The widespread adoption of AI-based imaging technologies by insurers reflects a growing recognition of their potential to transform healthcare delivery and improve patient care.
What's Next?
Starting October 1, 2025, Cigna health plans will cover AI-QCT/AI-CPA imaging for patients meeting specific clinical criteria. This coverage expansion is expected to increase access to advanced cardiovascular imaging, potentially leading to improved patient outcomes. As more insurers adopt AI-based technologies, the healthcare industry may see a shift towards more personalized and precise treatment options. The continued integration of AI in healthcare could drive innovation and improve the efficiency of care delivery.
